General form of registration statement for all companies including face-amount certificate companies

CONDENSED BALANCE SHEETS

v2.4.0.8
CONDENSED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2014
Dec. 31, 2013
Dec. 31, 2012
Current assets:      
Cash $ 8,853 $ 11,798 $ 18,102
Receivables 3,743 4,818 4,646
Prepaid expenses and other current assets 216 204 687
Total current assets 12,812 16,820 23,435
Property and equipment, net 1,437 1,603 1,392
Total Assets 14,249 18,423 24,827
Current liabilities:      
Accounts payable 3,832 5,118 3,767
Accrued clinical trials expenses 131 118 532
Other accrued liabilities 364 293 219
Deferred contract revenue 3,494 5,317 14,375
Current portion of long-term debt   0 2,500
Total current liabilities 7,821 10,846 21,393
Warrant liabilities 2,965 1,817 8,240
Royalty liability   0 8,962
Long-term debt, net of discount   0 9,360
Total Liabilities 10,786 12,663 47,955
Commitments and contingencies        
Stockholders' equity:      
Preferred stock, $0.001 par value per share; 5,000,000 shares authorized, none issued and outstanding at December 31, 2013 and 2012.   0 0
Common stock, at amounts paid-in, $0.001 par value per share; 125,000,000 shares authorized, 88,794,222 and 75,215,713 shares issued and outstanding at December 31, 2013 and 2012, respectively. 284,448 284,485 265,986
Additional paid-in capital 22,078 21,692 21,014
Accumulated deficit (303,063) (300,417) (310,128)
Total stockholders’ equity 3,463 5,760 (23,128)
Total Liabilities and Stockholders’ Equity (Deficit) $ 14,249 $ 18,423 $ 24,827